WVE

2.5605.88%
HL

Heidi L. Wagner

Independent Director

Ms. Heidi L. Wagner, Esq., J.D., is Chief Operating Officer of Meter Health, Inc. She served as Global Head of Government Affairs of ElevateBio, LLC since March 2023 until November 2025 and served as its Senior Vice President until February 2025. She joined ElevateBio, LLC in March 2023. She is a highly accomplished industry leader with a strong and proven track record in delivering for patients and families by establishing and executing strategies globally across government affairs, public policy and patient advocacy. She serves as Independent Director of Wave Life Sciences, Inc. since September 4, 2019. Ms. Wagner had been Senior Vice President of government affairs and policy at Global Blood Therapeutics, Inc. since August 21, 2018 till January 2021. Ms. Wagner served as Senior Vice President of Global Government Affairs at Alexion Pharmaceuticals, Inc., since September 2012 until 2018. Ms. Wagner served as Vice President of Global Government Affairs of Alexion Pharmaceuticals, Inc., from September 2009 to September 2012. Ms. Wagner is an attorney many years of experience in health care legislative and regulatory policy issues. Prior to joining Alexion Pharmaceuticals, Inc. in 2009, Ms. Wagner served as Senior Director of Government Affairs for Genentech from 2000 to 2009 and as Director, Government Affairs from 1998 to 1999 and also consulted for a variety of health plans, biopharmaceutical and other health care-related companies. She served as Health Policy Director and Consultant at Healthcare Leadership Council and in various roles at Epstein Becker & Green and Groom & Nordberg and the U.S. House of Representatives. Ms. Wagner's policy expertise broadly encompasses issues relating to biotechnology/pharmaceuticals and public payer policy. She has led numerous federal legislative/regulatory strategic efforts relating to, among other issues, Medicare payment policy, follow-on biologics/biosimilars and HIPAA/health privacy; and advises regularly on the commercial implications of such federal policy and political initiatives. From 2015 to 2018, she also served as a member of the board of directors of the European Confederation of Pharmaceutical Entrepreneurs. Ms. Wagner received a Bachelor of Science degree in Journalism and Mass Communication from the University of Colorado in Boulder and earned a J.D. from George Mason University School of Law.

Positions